市場調査レポート
商品コード
1467848
静脈内治療と静脈アクセス市場:タイプ、用途、エンドユーザー、地域別、2024~2032年Intravenous Therapy and Vein Access Market by Type, Application, End User, and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
静脈内治療と静脈アクセス市場:タイプ、用途、エンドユーザー、地域別、2024~2032年 |
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2~3営業日
|
世界の静脈内治療と静脈アクセス市場規模は2023年に251億米ドルに達しました。今後、IMARC Groupは、2024~2032年にかけて4.64%の成長率(CAGR)を示し、2032年までに382億米ドルに達すると予測しています。慢性疾患の蔓延、交通事故の増加、静脈内治療の利点に対する消費者の意識の高まりが、市場を牽引する主要要因のひとつです。
静脈内(IV)療法は、静脈を通じて血流に直接水分、薬剤、栄養を投与する医療処置です。この手技は、さまざまな症状や病気を治療するために、病院やクリニック、その他の医療施設で一般的に使用されています。静脈アクセスとは、静脈内治療を行うために静脈に入ることです。医療専門家は通常、針を使用して皮膚を穿刺し、静脈にアクセスしますが、静脈が細い、または損傷している、脱水、肥満などの要因により、一部の患者さんには課題がある場合があります。点滴療法にはいくつかの種類があり、脱水症に対する生理食塩水、感染症に対する抗生物質、がん治療に対する化学療法などがあります。また、病状を治療するだけでなく、予防接種やビタミンの投与など、予防的な意味合いでも点滴療法が行われることがあります。
がん、糖尿病、自己免疫疾患など、長期的な投薬とモニタリングを必要とする慢性疾患や生活習慣病の有病率の増加が、主に静脈内(IV)療法と静脈アクセス市場の世界の成長を牽引しています。このほか、交通事故の発生件数の増加や外傷症例の急増も市場成長に寄与しています。さらに、静脈内治療と静脈アクセスの利点に関する消費者の意識の高まりと、重症患者治療の増加が、市場に有益な成長機会をもたらしています。これに伴い、低侵襲処置への嗜好が変化していることも、重要な成長促進要因として作用しています。これに加えて、必要な時間と労力を削減し、感染リスクを低下させ、手技の精度を向上させる医療業界における数々の技術的進歩が、市場に明るい展望を生み出しています。これと同時に、新たな治療法、薬剤、機器を革新するための研究開発(R&D)活動への広範な投資が、市場の拡大を後押ししています。さらに、医療支出の増加、病院数の増加、在宅医療の普及、高齢者人口の増加が、市場の成長を強化しています。
The global intravenous (IV) therapy and vein access market size reached US$ 25.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.64% during 2024-2032. The growing prevalence of chronic diseases, the increasing incidences of road accidents, and the rising consumer awareness about the benefits of IV therapy represent some of the key factors driving the market.
Intravenous (IV) therapy is a medical procedure that involves administering fluids, medications, and nutrition directly into the bloodstream through a vein. This technique is commonly used in hospitals, clinics, and other healthcare facilities to treat various conditions and illnesses. Vein access is the process of entering a vein in order to administer IV therapy. A healthcare professional typically uses a needle to puncture the skin and access a vein, which can be challenging in some patients due to factors such as small or damaged veins, dehydration, and obesity. There are several types of IV therapy, including saline solutions for dehydration, antibiotics for infections, and chemotherapy for cancer treatment. In addition to treating medical conditions, IV therapy can also be used for preventative measures, such as receiving vaccinations and vitamins.
The increasing prevalence of chronic and lifestyle diseases, such as cancer, diabetes, and autoimmune diseases that require long-term medication and monitoring, is primarily driving the global intravenous (IV) therapy and vein access market growth. Besides this, the rising incidences of road accidents and the surging number of trauma cases are contributing to the market growth. Moreover, the escalating consumer awareness about the benefits of IV therapy and vein access and the rise in critical care therapies are presenting remunerative growth opportunities for the market. In line with this, the shifting preference for minimally invasive procedures is acting as another significant growth-inducing factor. In addition to this, numerous technological advancements in the healthcare industry to reduce the needed time and effort, lower the risk of infection, and improve the accuracy of the procedure are creating a positive outlook for the market. Concurrent with this, extensive investments in research and development (R&D) activities for innovating new therapies, drugs, and devices are aiding in market expansion. Furthermore, the increasing healthcare expenditure, rise in the number of hospitals, the widespread adoption of home healthcare, and the expanding geriatric population are strengthening the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global intravenous (IV) therapy and vein access market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type, application, and end user.
Implantable Ports
Intravenous Catheters
Hypodermic Needles
Infusion Pumps
Others
The report has provided a detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the type. This includes implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and others. According to the report, intravenous catheters represented the largest segment.
Nutrition and Buffer Solution
Volume Expander
Medication Administration
Blood Based Products
A detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the application has also been provided in the report. This includes nutrition and buffer solution, volume expander, medication administration, and blood-based products. According to the report, medication administration accounted for the largest market share.
Hospitals
Ambulatory Surgical Center
Clinics
The report has provided a detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the end user. This includes hospitals, ambulatory surgical centers, and clinics. According to the report, hospitals represented the largest segment.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for intravenous (IV) therapy and vein access. Some of the factors driving the North America intravenous (IV) therapy and vein access market included the growing prevalence of chronic diseases, the increasing number of road accidents, and the expanding geriatric population.
The report has also provided a comprehensive analysis of the competitive landscape in the global intravenous (IV) therapy and vein access market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AngioDynamics Inc., B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Fresenius SE & Co. KGaA, ICU Medical Inc., Medtronic plc, Tekni-Plex Inc., Teleflex Incorporated, Terumo Corporation, Vygon SAS, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.